- Home
- PANL vs ESPR Comparison
PANL vs ESPR Comparison
Compare PANL & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- ESPR
- Stock Information
- Founded
- PANL 1996
- ESPR 2008
- Country
- PANL United States
- ESPR United States
- Employees
- PANL N/A
- ESPR N/A
- Industry
- PANL Marine Transportation
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- PANL Consumer Discretionary
- ESPR Health Care
- Exchange
- PANL Nasdaq
- ESPR Nasdaq
- Market Cap
- PANL 357.3M
- ESPR 305.0M
- IPO Year
- PANL N/A
- ESPR 2013
- Fundamental
- Price
- PANL $4.76
- ESPR $1.44
- Analyst Decision
- PANL Strong Buy
- ESPR Buy
- Analyst Count
- PANL 1
- ESPR 7
- Target Price
- PANL N/A
- ESPR $6.36
- AVG Volume (30 Days)
- PANL 275.5K
- ESPR 4.4M
- Earning Date
- PANL 03-13-2025
- ESPR 03-04-2025
- Dividend Yield
- PANL 8.40%
- ESPR N/A
- EPS Growth
- PANL 8.62
- ESPR N/A
- EPS
- PANL 0.63
- ESPR N/A
- Revenue
- PANL $536,536,246.00
- ESPR $332,314,000.00
- Revenue This Year
- PANL $13.67
- ESPR $5.51
- Revenue Next Year
- PANL $6.04
- ESPR $1.42
- P/E Ratio
- PANL $7.71
- ESPR N/A
- Revenue Growth
- PANL 7.46
- ESPR 185.66
- 52 Week Low
- PANL $4.67
- ESPR $1.42
- 52 Week High
- PANL $8.32
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- PANL 36.75
- ESPR 35.82
- Support Level
- PANL $4.96
- ESPR $1.47
- Resistance Level
- PANL $5.06
- ESPR $1.75
- Average True Range (ATR)
- PANL 0.19
- ESPR 0.10
- MACD
- PANL -0.04
- ESPR 0.00
- Stochastic Oscillator
- PANL 8.82
- ESPR 6.06
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.